Publications by authors named "Halil Taskaynatan"

Claim this Profile
C
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making.
Özlem Kutlu, Damla Günenç, Duygu Ayaz, Özlem Özdemir, Halil Taşkaynatan

Diagnostics (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy.
Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel, Ozden Demir, Ayberk Bayramgil, Halil Taskaynatan

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy.
Halil Taskaynatan, Betul Ersoz, Ufuk Camanli, Baris Gezici, Feyza Arslan Tan

Nat Sci Sleep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study.
Okan Avcı, Yakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun, Murat Araz

J Geriatr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
Cihan Erol, Mehmet Ali Nahit Sendur, Irem Bilgetekin, Duygu Bayir Garbioglu, Jamshid Hamdard, Halil Taskaynatan

J Cancer Res Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, Basak Oyan Uluç, Devrim Cabuk, Halil Taskaynatan

Anticancer Drugs· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy-induced granulomatous reaction in patients with melanoma.
Halil Taskaynatan, Damla Gunenc, Sercan Ön, Ali Mizrak, Ozgur Samancilar

Melanoma Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer.
Yakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, Okan Avci, Ozkan Alan, Halil Taskaynatan

Bratisl Lek Listy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review.
Ozlem Ozdemir, Baha Zengel, Yasar Yildiz, Seray Saray, Ahmet Alacacioglu, Halil Taskaynatan

Sisli Etfal Hastan Tip Bul· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Mehmet Artaç, Nail Özhan

Eur Urol Focus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Nail Özhan, Burcu Çakar

Int J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinicopathological Significance of Basal Markers in Early-Stage Invasive Carcinoma of No Special Type of the Breast.
Fikret Dirilenoglu, Demet Arikan Etit, Halil Taskaynatan, Ferhan Elmali

Turk Patoloji Derg· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler, Halil Taskaynatan

J Cancer Res Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study].
Umut Varol, Ezgi Kaya, Utku Oflazoglu, Tarik Salman, Yasar Yildiz, Halil Taskaynatan

J BUON· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary study of serum Galectin-1 in breast cancer carcinogenesis [Izmir Oncology Group (IZOG) study].
Elif Gurel Cayir, Leyla Demir, Umut Varol, Murat Kemal Atahan, Tarik Salman, Halil Taskaynatan

J BUON· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group study.
Umut Varol, Yusuf Uzum, Adem Sengul, Ugur Bayram Korkmaz, Murtaza Parvizi, Halil Taskaynatan

Indian J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).
Utku Oflazoglu, Ahmet Alacacioglu, Umut Varol, Yuksel Kucukzeybek, Tarik Salman, Halil Taskaynatan

Support Care Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study.
Utku Oflazoglu, Ahmet Alacacioglu, Umut Varol, Yuksel Kucukzeybek, Tarik Salman, Halil Taskaynatan

Support Care Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosis.
Yasar Yildiz, Gokhan Kabadayi, Seyran Yigit, Yuksel Kucukzeybek, Ahmet Alacacioglu, Halil Taskaynatan

J BUON· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and related factors of sarcopenia in newly diagnosed cancer patients.
Utku Oflazoglu, Ahmet Alacacioglu, Umut Varol, Yuksel Kucukzeybek, Tarik Salman, Halil Taskaynatan

Support Care Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is adjuvant chemotherapy necessary for Luminal A-like breast cancer?
Halil Taskaynatan, Yuksel Kucukzeybek, Ahmet Alacacioglu, Yasar Yildiz, Tarik Salman

J BUON· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer.
Betul Bolat Kucukzeybek, Ibrahım V Bayoglu, Yuksel Kucukzeybek, Yasar Yıldız, Utku Oflazoglu, Halıl Taskaynatan

Pol J Pathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Monitoring Mean Platelet Volume Necessary in Breast Cancer Patients?
Halil Taskaynatan, Ahmet Alacacioglu, Yuksel Kucukzeybek, Umut Varol, Yasar Yildiz

Open Med (Wars)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.
Murat Akyol, Ahmet Alacacioglu, Leyla Demir, Yuksel Kucukzeybek, Yasar Yildiz, Halil Taskaynatan

Cancer Biomark· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.
Tarik Salman, Leyla Demir, Umut Varol, Murat Akyol, Utku Oflazoglu, Halil Taskaynatan

J BUON· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis